A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea

Release of Study Results Coincides with National Stop Nausea Day on May 16th

What To Know

  • When describing the intensity of their nausea on a scale of 1 to 10 (10 being unbearable), “7” was the number used by most respondents to rate how overbearing their nausea is.
  • The survey was completed in December 2022 and consisted of a diverse group of consumers, with 82% of respondents evenly distributed between 25 and 65 years of age.

Reliefband®, an innovator in wearable technology that prevents and treats nausea and vomiting, has released its First Annual State of Nausea study. According to the survey findings, nausea is epidemic in the United States, with 73% of Americans reporting that they suffer from nausea regularly. Of those who suffer from nausea, 76% stated that their symptoms prevent them from enjoying life to the fullest.

Released on National Stop Nausea Day, the study sheds light on the magnitude of the problem and its far-reaching consequences. 31% of Americans reported experiencing nausea every day, 26% at least once weekly, and 16% once each month. Making matters worse, more than half of the respondents (55%) indicated that they had yet to find an effective solution for their condition. This underscores previous research by Reliefband in 2020 that found sufferers often rely on home remedies, holistic techniques, over the counter and prescription medications, behavior modification, or just suffer with the condition doing nothing at all.

“Nausea is too often trivialized. The reality is that it ruins plans and leads to missed opportunities,” explained Rich Ransom, President, and CEO at Reliefband. “Nausea symptoms are felt everywhere – the mouth, throat, chest, stomach, or throughout your entire body. This robs sufferers of motivation, productivity, and sleep. It also hinders plans and life experiences. Everyday activities become more complicated, and our research shows that individuals suffering from nausea avoid social gatherings, certain foods, and outdoor activities such as boating, fishing, and skiing.”

The study revealed how nausea can affect daily life in many unpleasant ways. More than 18% of respondents reported that their nausea actively hindered their ability to travel, while some could not socialize (3.2%) or even work (2.9%). These findings highlight how nausea extends beyond mere inconvenience for a large majority of the U.S. population.

When describing the intensity of their nausea on a scale of 1 to 10 (10 being unbearable), “7” was the number used by most respondents to rate how overbearing their nausea is. 58% said their discomfort level was seven through 10 on the scale. This echoes earlier research conducted by Reliefband, in which more than half of nausea sufferers (54%) said they experienced moderate to severe symptoms.

Most nausea was reportedly caused by motion sickness: 49.4% of respondents attributed their symptoms to transport, including seasickness (26.0%), carsickness (11.9%), trainsickness (9.6%), and airsickness (1.9%). Other motion-related triggers mentioned by respondents included virtual-reality gaming (9.2%) and amusement park rides (1.6%).

Other common causes of nausea reported in the study included health and mental health issues such as morning sickness, anxiety, chemotherapy treatment, migraines, and post-operative effects. Concerning morning sickness, nausea, and vomiting affect up to 80% of pregnant women, according to a study published by the National Institutes of Health. Taking into account that 3.7 million babies were born in the U.S. in 2022, morning sickness affected nearly three million expectant mothers last year alone.

Reliefband’s First Annual State of Nausea study employed an online survey to collect data from 5,300 U.S. respondents. The survey was completed in December 2022 and consisted of a diverse group of consumers, with 82% of respondents evenly distributed between 25 and 65 years of age.

National Stop Nausea Day is observed every year in the U.S. on the third Tuesday in May. The purpose of the day is to give a voice to nausea sufferers, which affects millions of Americans daily. This day is intended to raise awareness of the causes of nausea, its pervasiveness among Americans, and to create a dialog on innovative treatment options. In observance of National Stop Nausea Day on May 16th, Reliefband’s entire line of anti-nausea wearables are $50 off when using promo code “STOP” at www.reliefband.com.

Reliefband is committed to addressing the urgent issue of nausea with wearable therapeutic technology that transforms how nausea and vomiting are managed. Reliefband devices use FDA-cleared, patented neuromodulation technology to target the underlying causes of nausea and provide fast, drug-free relief. Reliefband’s products gently stimulate the median nerve on the underside of the wrist, rebalancing the signals between the brain and the stomach. Reliefband wearables effectively reduce symptoms of nausea and vomiting due to motion sickness, morning sickness during pregnancy, chemotherapy, anxiety, hangovers, physician-diagnosed migraines, and as an adjunct to antiemetics in treating post-operative nausea.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.
SABIC advises the project was initiated together with the dialysis department at Jessa Hospital, one of the largest non-university medical cluster in the Limburg region of Flanders, Belgium.

By using this website you agree to accept Medical Device News Magazine Privacy Policy